Trilateral Project 24.1-Biotechnology 106

A claim to a monoclonal antibody directed against a sufficiently disclosed antigen (protein) would be considered to meet the enablement requirement, see (9) above. However, the specific monoclonal antibody obtained in the working example would not fulfill this requirement in the absence of a deposit.